New study aims to Fine-Tune treatment for blinding eye disease
Disease control
Not yet recruiting
This study tests a drug called faricimab (Vabysmo) in 64 adults with wet age-related macular degeneration, a leading cause of vision loss. Participants receive eye injections every 4 weeks for 4 doses, then the schedule is adjusted based on how the eye responds. The goal is to co…
Phase: PHASE4 • Sponsor: Junyeop Lee • Aim: Disease control
Last updated May 17, 2026 13:53 UTC